Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/33025
Title: | Bacteraemia due to Stenotrophomonas maltophilia: An analysis of 45 episodes. | Authors: | Spelman D.W.;Friedman N.D.;Korman T. ;Fairley C.K.;Franklin J.C. | Monash Health Department(s): | Infectious Diseases and Clinical Microbiology | Institution: | (Friedman, Franklin, Spelman) Dept. of Infectious Dis./Microbiol., Alfred Hospital, Prahran, Vic., Australia (Korman) Department of Infectious Diseases, Monash Medical Centre, Clayton, Vic., Australia (Fairley) Department of Public Health, University of Melbourne, Melbourne, Vic., Australia | Issue Date: | 19-Oct-2012 | Copyright year: | 2002 | Publisher: | W.B. Saunders Ltd (32 Jamestown Road, London NW1 7BY, United Kingdom) | Place of publication: | United Kingdom | Publication information: | Journal of Infection. 45 (1) (pp 47-53), 2002. Date of Publication: July 2002. | Abstract: | Objective: Stenotrophomonas maltophilia is an important nosocomial pathogen and a therapeutic challenge. A ten-year review of episodes of bacteraemia due to S. maltophilia was undertaken in light of reports of an increasing frequency of infection. Method(s): A retrospective analysis of bloodstream infections due to S. maltophilia at a tertiary care hospital in Melbourne, Australia. Cases were identified via microbiology laboratory reports, and relevant clinical data were collected from the medical record of each patient. Result(s): Eighty per cent of these 45 episodes were nosocomial. The most common characteristics in cases of bacteraemia were the presence of an indwelling central venous catheter (CVC) (38/45, 84%) and previous antibiotic therapy (33/45, 73%). There were 8 deaths (8/44, 18%) within 7 days of bacteraemia. A significant correlation was found between deaths and a failure to remove the CVC (P=0.01) or treat with appropriate antimicrobials (P=0.01). Antibiotic susceptibility testing revealed that isolates were most sensitive to sulphamethoxazole (80%), chloramphenicol (75.5%) and ceftazidime (64.5%). Conclusion(s): S. maltophilia is an important pathogen especially in the highly compromised host. Isolation of this organism from a blood culture should prompt a careful review of the patient with particular emphasis on removal of indwelling CVCs and commencement of appropriate antibiotic therapy. © 2002 The British Infection Society. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1053/jinf.2002.0978 | PubMed URL: | 12217732 [http://www.ncbi.nlm.nih.gov/pubmed/?term=12217732] | ISSN: | 0163-4453 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/33025 | Type: | Article |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.